Donepezil is used to manage the early symptoms of Alzheimer's Disease and is available as the Aricept preparation. It is a cholinesterase inhibitor, and increases acetylcholine levels in brain. Our lab group recently reviewed a paper by Takamatsu and colleages on donepezil's efficacy to block the conditioned reinforcing (place preference) and locomotor activating properties of cocaine and methamphetamine in mice. While it diminished the effects of cocaine, it was ineffective to alter methamphetamine's effects in this study. Considering the efficacy of other cholinergic ligands (e.g., lobeline) to alter methamphetamine's effects, these findings were surprising to us.
Reference - Takamatus Y. et al. (2006) Differential effects of donepezil on methamphetamine and cocaine depedencies. Ann NY Acad Sci 1074: 418
This research forum is for researchers, educators, and students to discuss the various factors associated with methamphetamine research. From basic science research to social issues, we seek to provide a comprehensive view and discussion of meth. If you would like to join this research forum, please email Dr. Mark Davis at mdavis@uwa.edu.
Subscribe to:
Post Comments (Atom)
This was most interesting to me since other cholinergic ligands alter meth effects.
ReplyDelete